Rapid Spread of Drug-Resistant Fungus C. auris in European Hospitals
New findings reveal that the drug-resistant fungus Candida auris is rapidly spreading across European hospitals, posing a significant threat to patient safety and infection control efforts. Early detection and coordinated response are crucial to stopping its spread.
Recent findings from the European Centre for Disease Prevention and Control (ECDC) confirm that Candida auris (formerly known as Candida auris), a multidrug-resistant fungus, is rapidly proliferating within hospitals across Europe. This is the fourth comprehensive survey indicating a concerning increase in cases, highlighting a significant threat to patients and public health systems.
The latest data show a worrying rise in case numbers, with many outbreaks expanding significantly, and several countries experiencing ongoing local transmission. Notably, the fungus’s ability to persist on various surfaces and medical equipment, coupled with its resistance to many antifungal medications, makes controlling its spread extremely challenging.
Between 2013 and 2023, over 4,000 cases have been reported across the EU/EEA countries. In 2023 alone, there were 1,346 recorded cases in 18 countries. Spain, Greece, Italy, Romania, and Germany have been the most affected, accounting for the majority of cases over the past decade.
Experts from the ECDC emphasize that while the situation is serious, early detection and strengthened infection control protocols can still mitigate further spread. Recent outbreaks in Cyprus, France, and Germany, alongside widespread regional transmission in Greece, Italy, Romania, and Spain, underscore the critical need for coordinated response efforts.
Despite some countries making progress in outbreak management, many lack comprehensive national surveillance systems—only 17 out of 36 countries currently monitor C. auris cases systematically. Additionally, just 15 countries have specific infection prevention and control guidance, while laboratory capacity for identifying the fungus varies, with many countries lacking the necessary facilities for effective detection.
The true extent of the problem is likely underestimated due to inconsistent reporting. The ECDC continues to assess the epidemiological situation, aiming to bolster national preparedness and response strategies. Improved surveillance, early case detection, and effective infection control guidelines are essential to prevent further dissemination of this dangerous pathogen.
Source: https://medicalxpress.com/news/2025-09-drug-resistant-fungus-auris-rapidly.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Impact of Kidney Transplants on Pregnancy Risks in Assisted Reproductive Technology
Recent research reveals that women with kidney transplants using assisted reproductive technology face increased pregnancy risks, but long-term outcomes remain positive, supporting ART as a safe option with proper care.
Insurers Contend with Rising Costs of GLP-1 Medications and Consider Patient Deprescription Strategies
Rising costs of GLP-1 medications lead insurers to restrict coverage and explore deprescription strategies, impacting patient care and weight management efforts.
Prepare for Flu Season: Get Your Flu Shot Early This Fall
Stay protected this fall by getting your flu shot early. Learn about the latest flu vaccines, optimal timing, and who should get vaccinated to prevent severe illness this season.
Enhanced Prostate Cancer Outcomes Through Advanced Imaging Techniques
A Danish study shows that using PSMA PET/CT imaging before salvage radiotherapy significantly enhances survival rates in men with recurrent prostate cancer, supporting its role in personalized treatment planning.